The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Article Reports on Neurostimulation for Occipital Neuralgia

Aug. 21, 2019 - A case series and literature review reports on high cervical spinal cord stimulation for occipital neuralgia. (Journal of Pain Research)

Center Enrolls Patients in Clinical Trial of Deep Brain Stimulation for Depression

Aug. 20, 2019 - Patients are still being accepted for enrollment in a clinical trial of deep brain stimulation for treatment-resistant depression at the University of Texas Health Science Center at Houston. (KHOU-11)

Researchers Seek to Determine Effect of Deep Brain Stimulation on Dopamine Levels

Aug. 20, 2019 - Researchers used PET scanning to look for signs of changing dopamine levels in the brains of Parkinson's disease patients who were receiving deep brain stimulation therapy. (Newswise)

Company Offers Consumer Device to Provide Transcranial Alternating Current Stimulation to the Prefrontal Cortex

Aug. 20, 2019 - A consumer device that provides noninvasive transcranial aternating current stimulation to the prefrontal cortex is being marketed to adults aged 40 and older. (Digital Journal)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM